|
Name |
Stemphyperylenol
|
Molecular Formula | C20H16O6 | |
IUPAC Name* |
(1S,6bS,7S,12bS)-1,4,7,10-tetrahydroxy-1,2,6b,7,8,12b-hexahydroperylene-3,9-dione
|
|
SMILES |
C1[C@@H]([C@H]2C3=C4[C@@H]([C@H](CC(=O)C4=C(C=C3)O)O)C5=C2C(=C(C=C5)O)C1=O)O
|
|
InChI |
InChI=1S/C20H16O6/c21-9-3-1-7-15-11(23)5-14(26)20-10(22)4-2-8(18(15)20)16-12(24)6-13(25)19(9)17(7)16/h1-4,11-12,15-16,21-24H,5-6H2/t11-,12-,15+,16+/m0/s1
|
|
InChIKey |
MCWOXLPZYFOWRX-YXAMBPQSSA-N
|
|
Synonyms |
stemphyperylenol; (+)-Stemphyperylenol; 102694-33-7; 6174N766ZN; 3,9-Perylenedione, 1,2,6b,7,8,12b-hexahydro-1,4,7,10-tetrahydroxy-, (1S,6bS,7S,12bS)-; (1S,6bS,7S,12bS)-1,4,7,10-tetrahydroxy-1,2,6b,7,8,12b-hexahydroperylene-3,9-dione; UNII-6174N766ZN; CHEMBL4649152; DTXSID50908002; CHEBI:141330; 3,9-Perylenedione, 1,2,6b,7,8,12b-hexahydro-1,4,7,10-tetrahydroxy-, (1S-(1alpha,6balpha,7alpha,12balpha))-; HY-142912; CS-0373477; Q21547214; 1,4,7,10-tetrahydroxy-1,2,6b,7,8,12b-hexahydroperylene-3,9-dione; 3,9-PERYLENEDIONE, 1,2,6B,7,8,12B-HEXAHYDRO-1,4,7,10-TETRAHYDROXY-, (1S-(1.ALPHA.,6B.ALPHA.,7.ALPHA.,12B.ALPHA.))-
|
|
CAS | 102694-33-7 | |
PubChem CID | 190433 | |
ChEMBL ID | CHEMBL4649152 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 352.3 | ALogp: | 1.5 |
HBD: | 4 | HBA: | 6 |
Rotatable Bonds: | 0 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 115.0 | Aromatic Rings: | 5 |
Heavy Atoms: | 26 | QED Weighted: | 0.577 |
Caco-2 Permeability: | -5.861 | MDCK Permeability: | 0.00000330 |
Pgp-inhibitor: | 0 | Pgp-substrate: | 0.296 |
Human Intestinal Absorption (HIA): | 0.903 | 20% Bioavailability (F20%): | 0.906 |
30% Bioavailability (F30%): | 1 |
Blood-Brain-Barrier Penetration (BBB): | 0.018 | Plasma Protein Binding (PPB): | 94.97% |
Volume Distribution (VD): | 0.587 | Fu: | 12.04% |
CYP1A2-inhibitor: | 0.795 | CYP1A2-substrate: | 0.052 |
CYP2C19-inhibitor: | 0.024 | CYP2C19-substrate: | 0.063 |
CYP2C9-inhibitor: | 0.026 | CYP2C9-substrate: | 0.906 |
CYP2D6-inhibitor: | 0.033 | CYP2D6-substrate: | 0.146 |
CYP3A4-inhibitor: | 0.005 | CYP3A4-substrate: | 0.039 |
Clearance (CL): | 3.959 | Half-life (T1/2): | 0.785 |
hERG Blockers: | 0.003 | Human Hepatotoxicity (H-HT): | 0.114 |
Drug-inuced Liver Injury (DILI): | 0.921 | AMES Toxicity: | 0.771 |
Rat Oral Acute Toxicity: | 0.313 | Maximum Recommended Daily Dose: | 0.981 |
Skin Sensitization: | 0.386 | Carcinogencity: | 0.145 |
Eye Corrosion: | 0.005 | Eye Irritation: | 0.235 |
Respiratory Toxicity: | 0.942 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC005474 | 1.000 | D0R9WP | 0.289 | ||||
ENC003652 | 0.570 | D0R3JB | 0.286 | ||||
ENC005311 | 0.570 | D07JHH | 0.285 | ||||
ENC003252 | 0.570 | D07MGA | 0.279 | ||||
ENC005389 | 0.516 | D0H1AR | 0.279 | ||||
ENC000835 | 0.516 | D08LTU | 0.272 | ||||
ENC002281 | 0.485 | D01XDL | 0.269 | ||||
ENC000881 | 0.485 | D0S0LZ | 0.268 | ||||
ENC003960 | 0.464 | D0H6QU | 0.265 | ||||
ENC002856 | 0.464 | D0AZ8C | 0.259 |